Published in Oral Dis on January 01, 2014
A randomized trial of ethyl lauroyl arginate-containing mouthrinse in the control of gingivitis. J Clin Periodontol (2015) 0.75
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47
Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. BMJ (2012) 4.79
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer (2005) 4.55
Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme. BJU Int (2012) 4.01
Alcohol poisoning is a main determinant of recent mortality trends in Russia: evidence from a detailed analysis of mortality statistics and autopsies. Int J Epidemiol (2008) 3.56
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol (2003) 3.31
Breast cancer. Lancet (2005) 3.27
'Environment' in cancer causation and etiological fraction: limitations and ambiguities. Carcinogenesis (2007) 3.20
Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women. J Natl Cancer Inst (2003) 3.20
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer (2005) 3.02
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet (2003) 2.95
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology (2002) 2.94
Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database. Lancet Oncol (2013) 2.91
Tobacco smoking and cancer: a meta-analysis. Int J Cancer (2008) 2.64
Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer (2005) 2.63
Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality. BJU Int (2008) 2.60
Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer (2011) 2.43
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Causes of death among Belgian professional military radar operators: a 37-year retrospective cohort study. Int J Cancer (2009) 2.17
Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood (2006) 2.06
Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation (2005) 2.01
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst (2007) 1.97
Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int (2003) 1.91
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol (2003) 1.84
Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol (2012) 1.78
Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol (2004) 1.71
The challenge of cancer control in Africa. Nat Rev Cancer (2008) 1.71
Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. Int J Cancer (2006) 1.71
A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer (2005) 1.70
Incremental detection rate of prostate cancer by real-time elastography targeted biopsies in combination with a conventional 10-core biopsy in 1024 consecutive patients. BJU Int (2014) 1.66
EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) (2011) 1.65
Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol (2004) 1.65
Mouthwash and oral cancer risk quantitative meta-analysis of epidemiologic studies. Ann Agric Environ Med (2012) 1.62
Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int (2007) 1.61
Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women. Cancer Causes Control (2010) 1.61
Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control (2004) 1.59
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58
Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2008) 1.57
The future of the nicotine-addiction market. Lancet (2003) 1.55
Curbing the liver cancer epidemic in Africa. Lancet (2008) 1.54
The prevalence of urinary incontinence in community-dwelling married women: a matter of definition. BJU Int (2004) 1.54
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays. Tumour Biol (2012) 1.52
The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies. BJU Int (2007) 1.50
Declining mortality from bladder cancer in Europe. BJU Int (2007) 1.49
The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int (2008) 1.49
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet (2006) 1.47
Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.43
Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol (2004) 1.42
Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer (2004) 1.38
Leveling of prostate cancer mortality in Western Europe. Prostate (2004) 1.34
Fruit and vegetable consumption and lung cancer risk: updated information from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer (2007) 1.33
Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis (2006) 1.32
Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev (2002) 1.30
Do Polybrominated Diphenyl Ethers (PBDEs) Increase the Risk of Thyroid Cancer? Biosci Hypotheses (2008) 1.29
Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States). Cancer Causes Control (2003) 1.26
Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Joint Surg Am (2003) 1.24
Genetic polymorphisms in the oxidative stress pathway and susceptibility to non-Hodgkin lymphoma. Hum Genet (2006) 1.24
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer (2007) 1.21
Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and Taiwan. Cancer Sci (2010) 1.21
A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst (2005) 1.20
A melanoma epidemic in Iceland: possible influence of sunbed use. Am J Epidemiol (2010) 1.15
Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.15
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol (2008) 1.14
Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol Biomarkers Prev (2009) 1.13
ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. J Natl Cancer Inst (2003) 1.10
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer (2014) 1.10
RE: Relationship between sunbed use and melanoma risk in a large case-control study in the United Kingdom. Int J Cancer (2012) 1.09
Genetic alterations in the PI3K pathway in prostate cancer. Anticancer Res (2009) 1.09
Foods, nutrients and prostate cancer. Cancer Causes Control (2004) 1.09
Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol (2006) 1.08
Strength/endurance training versus endurance training in congestive heart failure. Med Sci Sports Exerc (2002) 1.08
Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA. Cancer Epidemiol Biomarkers Prev (2006) 1.07
A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened. Cancer (2013) 1.07
Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin (2009) 1.05
Menstrual and reproductive factors and risk of non-Hodgkin's lymphoma among Connecticut women. Am J Epidemiol (2004) 1.04
Reviews on sun exposure and artificial light and melanoma. Prog Biophys Mol Biol (2011) 1.02
Cancer survival statistics should be viewed with caution. Lancet Oncol (2007) 1.02
Prevalence of main cancer lifestyle risk factors in Europe in 2000. Eur J Cancer (2010) 1.01
Identification of non-Hodgkin's lymphoma prognosis signatures using the CTGDR method. Bioinformatics (2009) 1.01
Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™). BJU Int (2011) 1.01
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study. Eur Urol (2002) 1.00
Early growth, adult body size and prostate cancer risk. Int J Cancer (2003) 0.99
Past medical history and pancreatic cancer risk: Results from a multicenter case-control study. Ann Epidemiol (2010) 0.99
Ultraviolet radiation exposure and risk of non-Hodgkin's lymphoma. Am J Epidemiol (2007) 0.99
Does "clock" matter in prostate cancer? Cancer Epidemiol Biomarkers Prev (2006) 0.99
Blood transfusion and risk of non-Hodgkin's lymphoma in Connecticut women. Am J Epidemiol (2004) 0.98
The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int (2008) 0.98
Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Blood (2010) 0.97
Mammography screening before introduction of the national breast screening programme in Norway. Int J Cancer (2012) 0.95
Effect of screening mammography on breast cancer incidence. N Engl J Med (2013) 0.95
Cigarette smoking, glutathione-s-transferase M1 and t1 genetic polymorphisms, and breast cancer risk (United States). Cancer Causes Control (2002) 0.93
Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients. Eur J Cancer (2011) 0.93
Costs of care after hospital discharge among women with a femoral neck fracture. Clin Orthop Relat Res (2003) 0.93